The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid
- PMID: 3216215
- PMCID: PMC1033125
- DOI: 10.1136/jnnp.51.8.1100
The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid
Abstract
Measurement of cerebrospinal fluid (CSF) levels of the minor dopamine metabolite 3,4-dihydroxyphenylacetic acid in neonates and children indicates that a rapid decline (approximately 90%) occurs in the first 2 years of life. The much less rapid ontogenetic decline seen for the predominant dopamine metabolite, homovanillic acid (HVA), indicates that differing factors affect CSF levels of the two acid metabolites. Further study is required to determine which compound more closely reflects ontogenetic changes in dopamine functioning.
Similar articles
-
Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography.Psychopharmacologia. 1975 Apr 30;42(1):57-6. doi: 10.1007/BF00428826. Psychopharmacologia. 1975. PMID: 1153623
-
Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.Am J Vet Res. 1988 Aug;49(8):1302-6. Am J Vet Res. 1988. PMID: 2459997
-
Hemiballismus: changes in cerebrospinal fluid.Acta Neurol Scand. 1988 Aug;78(2):115-7. doi: 10.1111/j.1600-0404.1988.tb03631.x. Acta Neurol Scand. 1988. PMID: 2459894
-
Cerebrospinal fluid probenecid studies: a reinterpretation.Biol Psychiatry. 1983 Nov;18(11):1287-99. Biol Psychiatry. 1983. PMID: 6197100 Review.
-
Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?Med Biol. 1985;63(1):1-17. Med Biol. 1985. PMID: 2582215 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical